Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 2
2006 1
2007 1
2008 1
2009 1
2010 1
2018 1
2019 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate.
Ramos CR, Spisni A, Oyama S Jr, Sforça ML, Ramos HR, Vilar MM, Alves AC, Figueredo RC, Tendler M, Zanchin NI, Pertinhez TA, Ho PL. Ramos CR, et al. Among authors: vilar mm. Biochim Biophys Acta. 2009 Apr;1794(4):655-62. doi: 10.1016/j.bbapap.2008.12.010. Epub 2008 Dec 25. Biochim Biophys Acta. 2009. PMID: 19150418
Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase Ib Clinical Trial Targeting Healthy Young Women.
Santini-Oliveira M, Machado Pinto P, Santos TD, Vilar MM, Grinsztejn B, Veloso V, Paes-de-Almeida EC, Amaral MAZ, Ramos CR, Marroquin-Quelopana M, Coler R, Reed S, Ciol MA, Savino W, Parra JC, Almeida MSDS, Tendler M. Santini-Oliveira M, et al. Vaccines (Basel). 2022 Oct 15;10(10):1724. doi: 10.3390/vaccines10101724. Vaccines (Basel). 2022. PMID: 36298589 Free PMC article.
Correction: Tendler, M., et al. Current Status of the Sm14/GLA-SE Schistosomiasis Vaccine: Overcoming Barriers and Paradigms towards the First Anti-Parasitic Human(itarian) Vaccine. Trop. Med. Infect. Dis. 2018, 3, 121.
Tendler M, Almeida MS, Vilar MM, Pinto PM, Limaverde-Sousa G. Tendler M, et al. Among authors: vilar mm. Trop Med Infect Dis. 2019 Jan 19;4(1):16. doi: 10.3390/tropicalmed4010016. Trop Med Infect Dis. 2019. PMID: 30669457 Free PMC article.
Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.
Varaldo PB, Leite LC, Dias WO, Miyaji EN, Torres FI, Gebara VC, Armôa GR, Campos AS, Matos DC, Winter N, Gicquel B, Vilar MM, McFadden J, Almeida MS, Tendler M, McIntosh D. Varaldo PB, et al. Among authors: vilar mm. Infect Immun. 2004 Jun;72(6):3336-43. doi: 10.1128/IAI.72.6.3336-3343.2004. Infect Immun. 2004. PMID: 15155638 Free PMC article.
Mycobacterial codon optimization of the gene encoding the Sm14 antigen of Schistosoma mansoni in recombinant Mycobacterium bovis Bacille Calmette-Guérin enhances protein expression but not protection against cercarial challenge in mice.
Varaldo PB, Miyaji EN, Vilar MM, Campos AS, Dias WO, Armôa GR, Tendler M, Leite LC, McIntosh D. Varaldo PB, et al. Among authors: vilar mm. FEMS Immunol Med Microbiol. 2006 Oct;48(1):132-9. doi: 10.1111/j.1574-695X.2006.00133.x. FEMS Immunol Med Microbiol. 2006. PMID: 16965361 Free article.
13 results